Youssef Bennani

Chief Executive Officer at

Find Therapeutics

65 year

87 connections

Health Technology

Commercial Services

Consumer Services

Profile

Youssef L.
Bennani is currently Chief Executive Officer at Neurasic Therapeutics, Inc., Chairman at Domain Therapeutics SA since 2014, Director at Find Therapeutics, Inc. since 2022, Member at the Institute of Corporate Directors, Chief Scientific Officer at adMare Bioinnovations, and Managing Partner at both CTI Life Sciences Fund and CTI Capital, Inc. since 2021.
Former roles include Chairman at Domain Therapeutics SA from 2014 to 2024, Independent Director at BELLUS Health, Inc. from 2017 to 2023, Vice President-Drug Innovation at Vertex Pharmaceuticals, Inc., Principal at Ligand Pharmaceuticals, Inc., AbbVie, Inc., and Athersys, Inc., Member at Neomed Institute, and Vice President-Research & Development, Site Head at Vertex Pharmaceuticals (Canada), Inc. from 2013 to 2017.
Education includes graduate studies at The Scripps Research Institute, undergraduate and doctorate degrees from the University of Montréal, and an MBA from Lake Forest Graduate School of Management conferred in 2000.

Youssef Bennani active positions

Companies	Position	Start
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Chairman	2014-03-31
Institute of Corporate Directors Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills	Corporate Officer/Principal	-
Find Therapeutics Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases	Chief Executive Officer	-
adMare Bioinnovations adMare Bioinnovations Miscellaneous Commercial ServicesCommercial Services adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.	Chief Tech/Sci/R&D Officer	-
Neurasic Therapeutics, Inc. Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops opiate-sparing and pain-relieving drugs	Chief Executive Officer	-
CTI Life Sciences Fund CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services Provides life science related services	Corporate Officer/Principal	2021-04-30
CTI Capital, Inc. CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins.	Private Equity Investor	2021-04-30

All active positions of Youssef Bennani

Former positions of Youssef Bennani

Companies	Position	End
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Chairman	2024-01-07
BELLUS HEALTH	Director/Board Member	2023-05-31
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

See the detail of Youssef Bennani's experience

Training of Youssef Bennani

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Youssef Bennani's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Vertex Pharmaceuticals, Inc. Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis	Health Technology
Ligand Pharmaceuticals, Inc. Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies	Health Technology
BELLUS Health, Inc. BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease	Health Technology
AbbVie, Inc. AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies	Health Technology
CTI Capital, Inc. CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins.	Finance
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Montréal University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Health Technology
Institute of Corporate Directors Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills	Commercial Services
Athersys, Inc. Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies	Health Technology
Lake Forest Graduate School of Management Lake Forest Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neomed Institute Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies	Health Technology
Vertex Pharmaceuticals (Canada), Inc. Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases	Commercial Services
adMare Bioinnovations adMare Bioinnovations Miscellaneous Commercial ServicesCommercial Services adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.	Commercial Services
Neurasic Therapeutics, Inc. Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops opiate-sparing and pain-relieving drugs	Health Technology
Find Therapeutics Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases	Health Technology
CTI Life Sciences Fund CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services Provides life science related services	Commercial Services